Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer - Related Studies

Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00083148. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms

3	More general conditions related to this trial
		Breast Diseases
		Neoplasms
		Neoplasms by Site
		Skin Diseases

4	Interventions listed in this trial
		capecitabine
		irinotecan hydrochloride

5	Additional drug interventions recognized in this trial
		Camptothecin
		Irinotecan

6	More general drug interventions related to this trial
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		Roswell Park Cancer Institute
		National Cancer Institute (NCI)